In the disease retinitis pigmentosa (RP), disease genes directly cause the dysfunction and death of rod photoreceptors, the photoreceptor type that mediates vision in dim light, causing night blindness. Subsequently, the cone photoreceptors, which mediate color and daylight vision, also lose function and die. Dr. Cepko et al have suggested a model wherein cones are affected due to the dysregulated metabolism that follows rod death. They have begun to develop gene therapy to combat this, using adenovirus-associated vectors (AAV) to deliver genes that help cones fight oxidation and other forms of stress. Their progress in treating RP mice using such vectors will be presented.